TCR2 Therapeutics Inc.
TCRRDelisted Jun 1, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001750019
TCR2 Therapeutics Inc. was delisted on Jun 1, 2023; its insiders filed their last Form 4 on Feb 14, 2024; 59 institutions reported holding it in 13F filings for Q1 2023, worth $31.5M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding TCR2 Therapeutics Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 59 | 0 | −59 |
| Shares | 21.0M | 0 | −21.0M (−100.0%) |
| Value | $31.5M | $0 | −$31.5M (−100.0%) |
New holders (0)
Institutions that held TCR2 Therapeutics Inc. at the end of Q2 2023 but not at the end of Q1 2023.
None.
Sold out (59)
Institutions that held TCR2 Therapeutics Inc. at the end of Q1 2023 and filed for Q2 2023 without it.